Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Mar 15, 2025; 17(3): 98844
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.98844
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.98844
Figure 5 Network pharmacology and molecular docking analysis of chlorogenic acid intervention targets.
A: Protein-protein interaction network of the 14 chlorogenic acid intervention targets; B: Gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis results; C: Molecular docking results of chlorogenic acid with peroxisome proliferator activated receptor gamma, fatty acid binding protein 4, glutathione peroxidase 4, and cystine glutamate reverse transporter. GPX4: Glutathione peroxidase 4; PTGS2: Prostaglandin endoperoxide synthase 2; xCT: Cystine glutamate reverse transporter; AKR1C3: Aldo-keto reductase family 1 member C3.
- Citation: Wu L, Chen HY, Zhang JT, Yang RY, Wang ZB, Xue PS, Peng W, Li KX, Gao WH, Zeng PH. Chlorogenic acid induces hepatocellular carcinoma cell ferroptosis via PTGS2/AKR1C3/GPX4 axis-mediated reprogramming of arachidonic acid metabolism. World J Gastrointest Oncol 2025; 17(3): 98844
- URL: https://www.wjgnet.com/1948-5204/full/v17/i3/98844.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i3.98844